MIRA Pharmaceuticals, Inc. (MIRA) Stock
MIRA Pharmaceuticals stock price chart
MIRA stock quote & key statistics
MIRA Pharmaceuticals annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0 | -$10.4M | -$0.41 |
| FY2024 | $0 | -$7.9M | -$0.55 |
| FY2023 | $0 | -$12.0M | -$0.73 |
| FY2022 | $0 | -$7.1M | — |
| FY2021 | $0 | -$2.2M | — |
Fiscal year ending December 31. Source: company filings via EODHD.
About MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical development company focused on advancing treatments for neurologic and neuropsychiatric disorders through two pioneering neuroscience programs.
One of its key innovations is Ketamir-2, an oral ketamine analog with exclusive rights in the U.S., Canada, and Mexico. Ketamir-2 is currently in development to offer rapid antidepressant effects, targeting conditions such as treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder.
Additionally, MIRA Pharmaceuticals is exploring the therapeutic potential of MIRA-55, an oral pharmaceutical marijuana formulation aimed at alleviating anxiety and cognitive decline in adult patients, particularly those experiencing early-stage dementia.
Founded in 2020 and headquartered in Miami, Florida, MIRA Pharmaceuticals, Inc., formerly known as MIRA1a Therapeutics, Inc., continues to drive innovation in pharmaceutical research and development, with a strong commitment to addressing significant unmet medical needs in neurology and psychiatry.
MIRA Pharmaceuticals stock FAQ
What is the MIRA Pharmaceuticals stock ticker symbol?
MIRA Pharmaceuticals, Inc. trades on the NASDAQ under the ticker symbol MIRA.
What sector and industry is MIRA Pharmaceuticals in?
MIRA Pharmaceuticals, Inc. is classified in the Healthcare sector, Drug Manufacturers - General industry.
What were MIRA Pharmaceuticals's revenue and earnings last fiscal year?
MIRA Pharmaceuticals reported revenue of $0 and net income of -$10.4M in fiscal 2025, with earnings per share of -$0.41.
When did MIRA Pharmaceuticals go public?
MIRA Pharmaceuticals stock began trading on August 3, 2023.